TP53 and B-cell chronic lymphocytic leukemia: Among the numerous other published prognosis factors, only IGHV mutational status and the presence of TP53 mutations or deletions, are consensually accepted as predictive for CLL progression and resistance to therapy, respectively.5, 6, 7